Private Equity

4 insights on PE in Q4 — Strong activity to continue – Private equity investors were highly active in the healthcare space to close out 2019, according to a quarterly report from Provident Healthcare Partners

Q4-2019 Private Equity Industry Update – Private equity fundraising trends have remained stable through Q4, leading to a high reserve of dry powder available to deploy for new platforms and bolt on acquisitions. While the total number of deals was down relative to 2018, valuations continue to remain elevated, with 2019 bringing in $155.7 billion in total transaction value.

2020 Health Care Services Private Equity Symposium – Scott Davis is attending the conference taking place March 11-12 in Miami.

Comprehensive Autism Center , an autism services provider offering in-home and center-based ABA therapies, has been acquired by the Speech Pathology Group (SPG), a portfolio company of Ridgemont Equity Partners.

Use of Third Party Debt in Private Equity Transactions – Episode 10 of Provident’s Healthcare Dealcast

PE investment in gastroenterology will likely continue into 2020 — 3 insights – Abe M’Bodj, an associate at Provident, spoke to Becker’s ASC Review about the recent transactions and what’s on the horizon for the gastroenterology sector.

An orthopedic practice nearby could be considering PE backing — here’s why it matters – Robert Aprill, a senior associate at Provident, spoke to Becker’s ASC Review about the recent transactions and what’s on the horizon for orthopedics.

Orthopedic investments in Q3 + how ASCs can benefit from private equity attention – Two new private equity platforms were established in the orthopedic sector in the third quarter of 2019, according to Provident Healthcare Partners’ “Q3-2019 Physician Services Update.”

Q3-2019 Private Equity Industry Update– Q3 of 2019 saw private equity funds raise $163B in aggregate capital. Despite the high amount of available capital to be deployed, 2019 has shown decreasing trends in deal volume and capital invested relative to 2018. Downward trends are expected to prompt sellers to seek to exit while purchase multiples are high.

Health Care MarketTrends | September 2019, Issue 2 – Law Firm Foley & Lardner LLP examine private equity investment in specialty areas of the healthcare industry, specifically dermatology and orthopedics. The article includes insight from Provident Healthcare Partners.

Investment & Consolidation in Addiction Treatment– The Substance Abuse sector has experienced significant investment activity as rising demand and significant fragmentation within the sector continue to create a ripe environment for consolidation.

Market Trends and M&A in Home Health / Hospice– The home health and hospice market remains one of the most fragmented sectors within healthcare services with many independent players holding significant market share in their respective geographies. Given the wide breadth of smaller companies, demand for home-based care, and the non capital-intensive nature of the business, there is significant opportunity in the space for both private equity and strategic-led consolidation.

Private Equity in Orthopedics: Before, During and After the Transaction – On Tuesday August 27, Provident co-hosted a webinar with Frier Levitt which focused on providing an update on the current state of the market, discussing what physicians should think about as they consider a transaction, and outlining what typical transaction terms look like for practices.

Private Equity Accelerating Consolidation In The CDMO Market – Bill Bolding and AJ Shekar share their insight on consolidation in the CDMO space.

Q2-2019 Private Equity Industry Update– Dry powder in the European and North American markets is currently at a new high while market uncertainty has impacted deal volume during the first half of 2019.

Private Equity Investment in Gastroenterology 2.0 – On Tuesday, July 23, Provident co-hosted a webinar which provided an update on the current state of the GI Market. The recording for the webinar is now available.

  • “Provident’s depth of experience and practical business savvy was demonstrated in their ability to cut through what sometimes looked like impasse.”

  • ”I have a tremendous amount of appreciation and gratitude to the Provident team for their hard work and diligence throughout this process. Each and every member of the Provident team is excellent at their jobs and it has been a pleasure working with such a professional team. Provident has provided outstanding guidance and counsel, and this deal could never have gotten done without Provident’s leadership.”

  • “We would not have been successful navigating the process without Provident’s hard work and active participation. They exceeded our expectations and we would highly recommend them to any health care company seeking a knowledgeable and engaged investment banking firm.”

  • “While the decision to sell our business was a difficult one, Provident vigilantly represented and protected our best interests throughout the transaction.  Provident was the right choice for Cascade and I would recommend their services to anyone.”

  • “A lot of investment bankers were interviewed, Provident was chosen. Provident delivered. My clients could not be happier.”

  • “Provident listened to our story, confirmed that our business was valuable and made us feel like this was the only transaction important to them.”

  • “After working with Provident on several transactions, it is evident that their extensive industry knowledge and deal expertise prove to be invaluable to their clients.”